Latest financial market updates and expert analysis
Analysis The numbers tell a story of whiplash. Marvell Technology has shed roughly 29 percent of its value in a single month, yet the stock still sits more than 118 percent...
The disconnect has rarely been starker: Micron Technology just posted the best quarterly results in its corporate history, yet the...
The numbers landing on Shell’s desk this earnings season tell a story of extraordinary tailwinds. Net income for the first...
European investors have been pouring money into global equity ETFs at an unprecedented clip, yet the MSCI World tracker now...
The Swiss asset manager’s decision to offload its majority holding in Polish convenience-store chain Żabka to Canada’s Alimentation Couche-Tard lands...
The gap between XPeng’s operational momentum and its stock price has rarely been wider. The electric vehicle maker just posted...
For nearly eight years, Alnylam has enjoyed something almost unheard of in biotech: a drug with no true rival for...
The numbers coming out of Cupertino last week were, by any conventional measure, exceptional. Revenue hit a record $109.4 billion...
A company that once promised investors hundreds of autonomous kitchen robots in the field by year-end is now targeting just...
The arithmetic of BioNTech’s share repurchase is straightforward on paper: a program of up to 24.9 million shares, capped at...
The tungsten producer’s journey toward a leaner exchange structure is nearly complete. Almonty Industries has now secured approval to delist...
